Fortress Biotech Inc (FBIO)

[conix]

On November 27, 2020, a class action lawsuit was filed against Fortress Biotech in United States District Court, Eastern District of New York.

According to the class action complaint, throughout the Class Period, the Fortress Biotech Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, according to the class action complaint, the Fortress Biotech Defendants made false and/or misleading statements and/or failed to disclose that IV Tramadol was not safe for the intended patient population, and that it was foreseeable to them that the FDA would not approve the New Drug Application for IV Tramadol.